Similarly, RANK-expressing breast and prostate cancer cell lines demonstrate upregulation of matrix metalloproteinase-1 (MMP-1) and subsequent migration and invasion upon RANKL administration (59). The gene discussed is MMP1; the disease is prostate cancer.